Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoViricides Becomes a Member Of Alliance for Biosecurity

NanoViricides, Inc., a nano-biopharmaceutical company specializing in the development of novel therapeutics to treat life-threatening viral infections, announced today that it has joined the Alliance for Biosecurity, an association comprised of a leading non-profit biosecurity organization and 14 other biopharmaceutical companies committed to improving the nation's biosecurity through the development of medical countermeasures to address a range of bioterrorism and natural pandemic threats.

NanoViricides Becomes a Member Of Alliance for Biosecurity

WEST HAVEN, CT | Posted on April 16th, 2007

Anita Cicero, Executive Director of the Alliance for Biosecurity, commented, "We are delighted to welcome NanoViricides into the Alliance. The company's work in the cutting-edge field of Nanomedicine, combined with its interest in contributing constructive policy suggestions to bolster national Flexible Defense initiatives, will be a significant asset to the Alliance. NanoViricides shares our organization's goal of rapidly accelerating the research, development, and procurement of medical countermeasures that will be needed to respond to both destabilizing pandemics and bioterrorism attacks. With NanoViricides' help, the Alliance will continue its efforts to maximize the promise of Project BioShield and the new Pandemic and All Hazards Preparedness Act."

"Our Rapid Response technologies fit in well with the Flexible Biodefense initiatives that are part of recent US Government acts," said Anil R. Diwan, Ph.D., President, NanoViricides, Inc.

"NanoViricides is honored to be associated with this prestigious organization whose strong membership, comprised of the principal actors in the BioSecurity field, includes some of the most prestigious pharma and biotechnology companies in the world," added Dr. Eugene Seymour, CEO, NanoViricides, Inc.

In other news, NanoViricides, Inc. announced that it has been informed that the nominating NASD member firm has responded to NASD comments on the form 15c2-11submission for NanoViricides to be listed on the over the counter bulletin board (OTC-BB).


About NanoViricides
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.

About the Alliance for Biosecurity-

The Alliance for Biosecurity is a collaboration among the Center for Biosecurity of the University of Pittsburg Medical Center, pharmaceutical companies, and biotechnology companies working to develop new technologies and vaccines and medicines for the Strategic National Stockpile. The Alliance seeks to engage government in a public-private partnership to usher in a new era in the prevention and treatment of severe infectious diseases that present global security threats. Member companies of the Alliance now include: Acambis, Inc., Avecia Biotechnology, Bavarian-Nordic, Cangene Corporation, DOR BioPharma, Inc., DynPort Vaccine Company, LLC, a CSC company, Elusys Therapeutics, Inc., Emergent BioSolutions, GlaxoSmithKline, Human Genome Sciences, Inc., Iomai Vaccines, NanoViricides, Inc., Novartis Vaccines & Diagnostics, Pfizer Inc., and PharmAthene, Inc.

For more information, please click here

NanoViricides, Inc.
Leo Ehrlich, 917-853-6440

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Design approach developed for important new catalysts for energy conversion and storage: New method could aid in design of pharmaceuticals and optical and data storage materials March 21st, 2018

RIT researchers improve fabrication process of nano-structures for electronic devices: Use of indium gallium phosphide with I-MacEtch processing shows promise for more cost effective fabrication and increased performance in devices from photonics to telecommunications March 20th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 20th, 2018

Leti and Inac Show Path to Creating Building Blocks of Quantum Processors With 28Si isotope in a CMOS Line: Fabrication of Isotopically Enriched, Industry-Compatible Wafers Points Way To Realizing Silicon Spin Quantum Bits with Enhanced Fidelity March 20th, 2018

Alliances/Trade associations/Partnerships/Distributorships

New era in high field superconducting magnets – opening new frontiers in science, nanotechnology and materials discovery January 9th, 2018

Leti Field Trials Demonstrate New Multicarrier Waveform for Rural, Maritime Broadband Radio: Field Trial in Orkney Islands Used New Filtered Multicarrier Waveform at 700MHz Band with Flexible Bandwidth Usage (Fragmented and Continuous Spectrum) December 18th, 2017

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project